[go: up one dir, main page]

IL195801A0 - Biomolecule-linked biomimetic scaffolds - Google Patents

Biomolecule-linked biomimetic scaffolds

Info

Publication number
IL195801A0
IL195801A0 IL195801A IL19580108A IL195801A0 IL 195801 A0 IL195801 A0 IL 195801A0 IL 195801 A IL195801 A IL 195801A IL 19580108 A IL19580108 A IL 19580108A IL 195801 A0 IL195801 A0 IL 195801A0
Authority
IL
Israel
Prior art keywords
biomolecule
linked
biomimetic scaffolds
biomimetic
scaffolds
Prior art date
Application number
IL195801A
Original Assignee
Univ California
Hashi Craig
Li Song
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2007/061253 external-priority patent/WO2007090102A2/en
Application filed by Univ California, Hashi Craig, Li Song filed Critical Univ California
Publication of IL195801A0 publication Critical patent/IL195801A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0041—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate characterised by the choice of an antithrombatic agent other than heparin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0076—Chemical modification of the substrate
    • A61L33/0082—Chemical modification of the substrate by reacting with an organic compound other than heparin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
IL195801A 2006-06-09 2008-12-08 Biomolecule-linked biomimetic scaffolds IL195801A0 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US80435006P 2006-06-09 2006-06-09
US86178006P 2006-11-30 2006-11-30
PCT/US2007/061253 WO2007090102A2 (en) 2006-01-27 2007-01-29 Biomimetic scaffolds
US11/668,448 US20070269481A1 (en) 2006-01-27 2007-01-29 Biomimetic Scaffolds
US92492607P 2007-06-05 2007-06-05
PCT/US2007/013736 WO2007146261A2 (en) 2006-06-09 2007-06-11 Biomolecule-linked biomimetic scaffolds

Publications (1)

Publication Number Publication Date
IL195801A0 true IL195801A0 (en) 2009-09-01

Family

ID=40243723

Family Applications (1)

Application Number Title Priority Date Filing Date
IL195801A IL195801A0 (en) 2006-06-09 2008-12-08 Biomolecule-linked biomimetic scaffolds

Country Status (9)

Country Link
EP (1) EP2023852A4 (en)
JP (1) JP2009540878A (en)
KR (1) KR20090024249A (en)
AU (1) AU2007258379A1 (en)
CA (1) CA2654840A1 (en)
IL (1) IL195801A0 (en)
MX (1) MX2008015695A (en)
RU (1) RU2009100654A (en)
WO (1) WO2007146261A2 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2599858A3 (en) * 2006-01-27 2013-09-18 The Regents of The University of California Biomimetic scaffolds
EP2962704A1 (en) 2008-10-07 2016-01-06 Nanonerve, Inc. Multilayer fibrous polymer scaffolds, methods of production and methods of use
CN102223910B (en) 2008-11-25 2014-05-07 爱德华兹生命科学公司 Apparatus for in situ expansion of prosthetic device
US8308798B2 (en) 2008-12-19 2012-11-13 Edwards Lifesciences Corporation Quick-connect prosthetic heart valve and methods
WO2011127478A1 (en) 2010-04-09 2011-10-13 Nanovasc, Inc. Sleeve for graft and method
EP2571977B1 (en) * 2010-05-17 2020-01-08 Yale University, Inc. System for seeding cells onto three dimensional scaffolds
US9090863B2 (en) 2010-05-17 2015-07-28 Pall Corporation System for seeding cells onto three dimensional scaffolds
EP2412798A1 (en) * 2010-07-27 2012-02-01 Gambro Lundia AB Biomimetic membrane for cell expansion
WO2012078472A2 (en) 2010-12-05 2012-06-14 Nanonerve, Inc. Fibrous polymer scaffolds having diametrically patterned polymer fibers
DK3011936T3 (en) * 2011-01-06 2019-05-20 Humacyte Tissue Manipulated Structures
CN102698323B (en) * 2012-05-14 2014-07-23 西南交通大学 Preparation method of anticlotting materials
ES2470495B1 (en) 2012-12-19 2015-05-14 Universidad De Castilla La Mancha Materials, methods and devices to stimulate and direct the proliferation and migration of neural progenitors and axonal and dendritic growth
KR101526308B1 (en) * 2013-01-23 2015-06-09 아주대학교산학협력단 Biomaterials containing contrast agent for tracing polymer in vivo and method for preparing the same
WO2015122478A1 (en) 2014-02-14 2015-08-20 日産化学工業株式会社 Active-ester-group-containing composition for producing fibers, and cell culture scaffold material using fibers produced from active-ester-group-containing composition
CN104153124B (en) * 2014-07-30 2016-11-02 东华大学 A kind of flexible rare earth oxide nanofiber membrane and preparation method thereof
CN104153123B (en) * 2014-07-30 2016-08-24 东华大学 A kind of flexible TiOx nano fibrous membrane and preparation method thereof
US20170232238A1 (en) 2014-08-06 2017-08-17 Edwars Litesciences Corporation Multi-lumen cannulae
WO2017031171A1 (en) * 2015-08-17 2017-02-23 The Johns Hopkins University In situ forming composite material for tissue restoration
JP7445274B2 (en) 2015-08-17 2024-03-07 ザ ジョンズ ホプキンス ユニバーシティ Mesenchymal cell-bound composites for tissue repair
CA2995855C (en) 2015-09-02 2024-01-30 Edwards Lifesciences Corporation Spacer for securing a transcatheter valve to a bioprosthetic cardiac structure
WO2017062375A1 (en) * 2015-10-05 2017-04-13 The Regents Of The University Of California Thermoreversible polymers and methods of use thereof
US10456245B2 (en) 2016-05-16 2019-10-29 Edwards Lifesciences Corporation System and method for applying material to a stent
CA3020238A1 (en) * 2016-05-16 2017-11-23 Edwards Lifesciences Corporation System and method for applying material to a stent
USD846122S1 (en) 2016-12-16 2019-04-16 Edwards Lifesciences Corporation Heart valve sizer
CA3082330A1 (en) 2018-01-23 2019-08-01 Edwards Lifesciences Corporation Prosthetic valve holders, systems, and methods
JP2021522926A (en) 2018-05-09 2021-09-02 ザ ジョンズ ホプキンス ユニバーシティ Nanofiber-hydrogel complex for soft tissue filling and enhanced regeneration
CA3099732A1 (en) 2018-05-09 2019-11-14 The Johns Hopkins University Nanofiber-hydrogel composites for cell and tissue delivery
USD908874S1 (en) 2018-07-11 2021-01-26 Edwards Lifesciences Corporation Collapsible heart valve sizer
CN110548187A (en) * 2019-09-16 2019-12-10 生纳科技(上海)有限公司 Instant puncture dialysis type nanofiber artificial blood vessel
WO2021061987A1 (en) 2019-09-27 2021-04-01 Edwards Lifesciences Corporation Modified prosthetic heart valve stent

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2000887A1 (en) * 1988-11-01 1990-05-01 Cecilia S.L. Ku Thromboresistant materials and methods for making same
US5053453A (en) * 1988-11-01 1991-10-01 Baxter International Inc. Thromboresistant materials and methods for making same
US5989244A (en) * 1994-11-15 1999-11-23 Gregory; Kenton W. Method of use of a sheet of elastin or elastin-based material
US5607475A (en) * 1995-08-22 1997-03-04 Medtronic, Inc. Biocompatible medical article and method
US6610004B2 (en) * 1997-10-09 2003-08-26 Orqis Medical Corporation Implantable heart assist system and method of applying same
US6889082B2 (en) * 1997-10-09 2005-05-03 Orqis Medical Corporation Implantable heart assist system and method of applying same
US6303136B1 (en) * 1998-04-13 2001-10-16 Neurotech S.A. Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
US6391333B1 (en) * 1999-04-14 2002-05-21 Collagen Matrix, Inc. Oriented biopolymeric membrane
US20050158362A1 (en) * 2000-06-23 2005-07-21 Wheatley Margaret A. Polymeric, fiber matrix delivery systems for bioactive compounds
US6893431B2 (en) * 2001-10-15 2005-05-17 Scimed Life Systems, Inc. Medical device for delivering patches
WO2006044904A2 (en) * 2004-10-15 2006-04-27 Vanderbilt University Nano- and micro-scale engineering of polymeric scaffolds for vascular tissue engineering
EP2599858A3 (en) * 2006-01-27 2013-09-18 The Regents of The University of California Biomimetic scaffolds

Also Published As

Publication number Publication date
JP2009540878A (en) 2009-11-26
KR20090024249A (en) 2009-03-06
EP2023852A4 (en) 2012-06-27
WO2007146261A2 (en) 2007-12-21
WO2007146261A3 (en) 2008-12-04
EP2023852A2 (en) 2009-02-18
RU2009100654A (en) 2010-07-20
AU2007258379A1 (en) 2007-12-21
CA2654840A1 (en) 2007-12-21
MX2008015695A (en) 2009-02-06

Similar Documents

Publication Publication Date Title
IL193082A0 (en) Biomimetic scaffolds
IL195801A0 (en) Biomolecule-linked biomimetic scaffolds
GB2474194B (en) Scaffolding
EP2249742A4 (en) Tissue engineering scaffolds
GB0807065D0 (en) Novel scaffolds
EP1994949A4 (en) Scaffold material
GB0713882D0 (en) Building component
AP2008004624A0 (en) Building block
ZA201102606B (en) Mortar
GB2437735B (en) Scaffolding
GB2437737B (en) Scaffolding
GB0713928D0 (en) Facade
GB2444262B (en) Scaffolding
ZA200809489B (en) Scaffold
ZA200807268B (en) Biomimetic scaffolds
GB0618247D0 (en) Building block
GB2441767B (en) Scaffolding
GB2437736B (en) Scaffolding
GB0617713D0 (en) Building component
GB0619357D0 (en) Scaffolding joint
HK1123826A (en) Biomimetic scaffolds
GB0621414D0 (en) Biomimetic structures
GB2435679B (en) Scaffolding
GB0603964D0 (en) Scaffolding bracket
GB0608836D0 (en) Scaffold